Phase 1 Study of Leukemic Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia
Phase of Trial: Phase I/II
Latest Information Update: 10 Dec 2013
At a glance
- Drugs DCP 001 (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- 28 May 2013 Clinical endpoints met (safety, feasability and positive immune response), according to CDPrime media release.
- 28 May 2013 Status changed from recruiting to completed, according to a DCPrime media release.
- 21 Feb 2012 Planned End Date changed from 1 Jul 2013 to 1 Sep 2012 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History